1. Academic Validation
  2. Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure-activity relationship and a pharmacophore model

Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure-activity relationship and a pharmacophore model

  • Bioorg Med Chem. 2016 Sep 15;24(18):3978-3985. doi: 10.1016/j.bmc.2016.06.036.
Gyanendra Kumar 1 Rakhi Agarwal 1 Subramanyam Swaminathan 2
Affiliations

Affiliations

  • 1 Biology Department, Brookhaven National Laboratory, Upton, NY 11973, USA.
  • 2 Biology Department, Brookhaven National Laboratory, Upton, NY 11973, USA. Electronic address: [email protected].
Abstract

Botulinum neurotoxins (BoNTs) are the most poisonous biological substance known to humans. They cause flaccid paralysis by blocking the release of acetylcholine at the neuromuscular junction. Here, we report a number of small molecule non-peptide inhibitors of BoNT serotype E. The structure-activity relationship and a pharmacophore model are presented. Although non-peptidic in nature, these inhibitors mimic key features of the uncleavable substrate peptide Arg-Ile-Met-Glu (RIME) of the SNAP-25 protein. Among the compounds tested, most of the potent inhibitors bear a zinc-chelating moiety connected to a hydrophobic and aromatic moiety through a carboxyl or amide linker. All of them show low micromolar IC50 values.

Keywords

Botulinum neurotoxin; Fluorene; Inhibitor; Pharmacophore; Structure–activity relationship.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-118851
    BoNT/E Inhibitor